discoveri
lymphocyt
reactiv
peptid
encod
exon
myelin
basic
protein
mbp
gene
multipl
sclerosi
ms
patient
drawn
attent
mbp
isoform
harbor
peptid
candid
autoantigen
previous
immunolog
studi
ms
almost
exclus
use
abund
kda
isoform
mbp
contain
exon
peptid
investig
experiment
allerg
encephalomyel
eae
also
focuss
kda
mbp
isoform
peptid
sinc
eae
anim
model
wide
use
studi
ms
examin
encephalitogen
potenti
exon
peptid
sjlj
mous
evid
increas
express
exon
isoform
remyelin
mous
cn
suggest
exon
cell
encephalitogen
capac
might
import
perpetu
relaps
eae
reae
experi
demonstr
exon
peptid
inher
immunogen
sjl
mice
eae
could
induc
adopt
transfer
exon
lymphocyt
furthermor
diseas
could
accentu
transfer
shortterm
exon
line
combin
adopt
transfer
antigen
challeng
exon
peptid
immunodomin
epitop
appear
local
segment
border
amino
acid
wide
accept
autoimmun
process
play
critic
role
pathogenesi
multipl
sclerosi
ms
demyelin
diseas
human
central
nervou
system
cn
howev
specif
compon
myelin
target
initi
andor
perpetu
diseas
remain
identifi
candid
autoantigen
ms
includ
kda
isoform
myelin
basic
protein
mbp
proteolipid
protein
myelinassoci
glycoprotein
myelin
oligodendrocyt
glycoprotein
johnson
et
al
richert
et
al
ota
et
al
sun
et
al
martin
et
al
chou
et
al
chou
et
al
although
kda
isoform
mbp
extens
investig
autoantigen
distinct
immun
reactiv
epitop
within
protein
consist
found
ms
patient
compar
healthi
control
pett
et
al
martin
et
al
b
recent
data
suggest
altern
isoform
mbp
also
consid
target
antigen
mbp
occur
multipl
isoform
gener
altern
splice
exon
primari
mbp
transcript
kamholtz
et
al
fritz
et
al
mous
five
isoform
kda
human
four
isoform
kda
identifi
fig
newman
et
al
roth
et
al
amino
acid
sequenc
encod
exon
segment
mbp
gene
exon
peptid
present
human
kda
isoform
found
recogn
lymphocyt
ms
patient
well
control
voskuhl
et
al
furthermor
multiplex
ms
famili
frequenc
exon
peptidespecif
cell
higher
frequenc
cell
specif
immunodomin
epitop
within
kda
isoform
voskuhl
et
al
fritz
mcfarlin
sinc
anim
model
experiment
autoimmun
encephalomyel
eae
wide
use
studi
ms
rain
et
al
investig
encephalitogen
potenti
exon
peptid
sjl
mous
exon
isoform
present
rel
small
amount
cn
adult
mous
well
adult
human
isoform
appear
produc
abund
earli
develop
remyelin
roth
et
al
jordan
et
al
kamholtz
et
al
development
studi
accumul
mbp
isoform
murin
myelin
indic
stoichiometr
proport
kda
isoform
chang
activ
myelin
adult
myelin
respect
barbares
et
al
exon
transcript
also
found
upregul
remyelin
murin
cn
subsequ
corona
virusmedi
demyelin
jordan
et
al
sinc
remyelin
occur
cyclic
manner
cours
relapsingremit
eae
reae
brown
et
al
rain
et
al
novel
regul
exon
express
prompt
us
examin
peptid
potenti
encephalitogen
studi
demonstr
exon
peptidespecif
cell
isol
anim
immun
exon
peptid
cell
encephalitogen
adopt
transfer
naiv
sjl
mice
furthermor
immunodomin
epitop
appear
locat
within
segment
border
amino
acid
femal
sjl
mice
obtain
jackson
laboratori
bar
harbor
mice
week
age
sensit
whole
myelin
basic
protein
gpmbp
prepar
adult
guinea
pig
spinal
cord
rockland
inc
gilbertsvil
pa
accord
procedur
deibler
et
al
gpmbp
almost
exclus
consist
kda
isoform
includ
peptid
kerlero
de
rosbo
et
al
exon
synthet
peptid
gener
solid
phase
method
hplc
purifi
puriti
aliquot
undergo
confirmatori
amino
acid
aa
composit
analysi
synthecellvega
biomolecul
corpor
columbia
md
two
peptid
use
exon
aa
sequenc
correspond
portion
murin
mbp
strictli
encod
exon
sequenc
follow
vpwlkqsrsplpsharsrpglchmyk
ii
exon
aa
sequenc
includ
aa
segment
aa
segment
encod
region
mbp
gene
exon
respect
sequenc
follow
pkrgsgkvpwlkqsrsplpsharsrpglchmyk
dshtrithi
concanavalin
cona
obtain
sigma
st
loui
mo
ppd
connaught
laboratori
willowdal
ontario
canada
hmbp
synthet
peptid
correspond
aa
kda
isoform
human
mbp
obtain
synthecel
columbia
md
quantiti
exon
dissolv
pb
emulsifi
equal
volum
complet
freund
adjuv
cfa
difco
laboratori
detroit
mi
control
pb
use
alon
emuls
mous
inject
subcutan
pg
inactiv
mycobacterium
tuberculosi
either
alon
variou
dose
exon
peptid
emuls
distribut
four
site
drain
inguin
axillari
lymph
node
anim
use
deriv
mbpreactiv
cell
ident
procedur
use
substitut
pg
gpmbp
immunogen
day
immun
drain
lymph
node
harvest
wash
resuspend
x
cellsml
either
exon
peptid
pgml
ppd
fgml
tissu
cultur
medium
tcm
medium
consist
fetal
calf
serum
penicillin
g
pyruv
nonessenti
amino
acid
glutamin
mm
day
cultur
co
cluster
plate
costar
cambridg
cell
harvest
resuspend
x
tcm
x
irradi
r
syngen
spleen
cell
day
later
viabl
cell
restimul
concentr
x
cellsml
exon
peptid
pgml
ppd
pgsml
irradi
apc
x
cellswel
ml
volum
day
determin
arithmet
mean
quadrupl
cultur
sem
equal
less
assay
stimul
index
si
calcul
divid
mean
cpm
cultur
incub
antigen
mitogen
mean
cpm
cultur
incub
media
alon
lymph
node
cell
x
ml
cultur
variou
concentr
antigen
mitogen
media
alon
cultur
maintain
day
roundbottom
microtit
plate
costar
cambridg
co
air
well
puls
final
h
cultur
pci
methylthymidin
amersham
corp
arlington
ht
il
cell
harvest
glass
fiber
filter
incorpor
radioact
quantit
betapl
counter
wallac
gaithersburg
md
result
end
cultur
period
viabl
cell
harvest
wash
resuspend
pb
inject
naiv
sjl
mice
x
cellsmous
fig
prolif
respons
sensit
lnc
exon
peptid
lnc
incub
h
media
alon
antigen
mitogen
concentr
indic
bracket
unit
pgml
prolifer
measur
incorpor
h
well
puls
assay
cultur
perform
quadrupl
sem
less
equal
lnc
obtain
mice
immun
exon
cfa
day
earlier
signific
respons
exon
found
multipl
experi
absenc
respons
gpmbp
basic
compris
exon
isoform
ppd
use
posit
control
mycobacterium
tuberculosi
present
immun
emuls
b
lnc
obtain
condit
incub
exon
exon
parallel
similar
respons
two
peptid
repeatedli
demonstr
hpmbp
peptid
correspond
amino
acid
isoform
human
mbp
use
neg
control
c
lnc
obtain
mice
immun
stimul
twice
vitro
promot
prolif
respons
similar
respons
absenc
reactiv
gpmbp
persist
illustr
specif
lnc
loss
reactiv
ppd
indic
protocol
select
exon
peptidereact
cell
exclus
popul
lnc
obtain
mice
immun
exon
stimul
twice
vitro
pattern
reactiv
similar
obtain
analog
experi
employ
cc
appropri
antigen
cfa
describ
section
sensit
lnc
resembl
mice
receiv
gpmbpsensit
lnc
parallel
experi
howev
mice
former
group
invari
develop
less
sever
diseas
greater
number
lnc
requir
diseas
induct
tabl
similar
result
obtain
use
immunogen
data
shown
attempt
enhanc
respons
exon
peptid
perhap
produc
sever
diseas
lnc
mice
immun
exon
stimul
twice
prior
transfer
lnc
incub
exon
peptid
two
cycl
separ
loday
rest
period
transfer
dose
x
cell
mous
phenotyp
analysi
demonstr
line
anim
adopt
transfer
cell
becam
ill
without
manipul
diseas
gener
sever
major
mice
paralyz
hind
limb
peak
diseas
tabl
anim
follow
sever
relaps
fig
patholog
analysi
yield
find
typic
eae
extens
inflammatori
demyelin
involv
entir
neuroaxi
lesion
appear
pure
demyelin
murin
model
eae
axon
dystrophi
wallerian
degener
rare
seen
fig
twenti
control
anim
receiv
restimul
ppdspecif
cell
fail
develop
either
clinic
histolog
evid
diseas
tabl
second
seri
experi
enhanc
encephalogen
exon
peptid
consist
first
sensit
recipi
lnc
clinic
cours
mice
inject
cell
line
specif
exon
peptid
lnc
obtain
mice
immun
exon
cfa
stimul
twice
vitro
inject
naiv
recipi
x
cellsmous
mice
examin
daili
sign
eae
grade
point
scale
diseas
sever
previous
describ
petinelli
et
al
repres
hindlimb
paralysi
repres
moribund
state
recipi
develop
eae
relapsingremit
cours
follow
muniz
donor
cell
reactiv
peptid
month
later
rechalleng
anim
fail
develop
eae
subcutan
inject
exon
peptid
cfa
techniqu
combin
adopt
transfer
antigen
challeng
origin
employ
induc
eae
reportedli
resist
strain
shaw
et
al
recipi
experi
display
clinic
sign
eae
within
day
post
antigen
challeng
includ
four
mice
initi
inject
x
cell
three
mice
inject
x
cell
five
mice
inject
x
cell
tabl
relapsingremit
cours
ensu
fig
histopatholog
examin
reveal
extens
inflammatori
lesion
along
entir
neuroaxi
larg
plaqu
ongo
demyelin
appar
spinal
cord
axon
dystrophi
wailerian
degener
spars
fig
cl
macrophag
laden
myelin
debri
abund
lesion
fig
c
blind
observ
note
presenc
exon
anim
area
recent
activ
superimpos
upon
longstand
lesion
contain
remyelin
fiber
fig
other
display
fibrillari
astrogliosi
begin
separafashion
day
post
transfer
repeat
experi
exhibit
clinic
featur
typic
eae
mice
inject
x
cell
inject
x
cell
mice
inject
x
cell
develop
obviou
neurolog
deficit
tabl
patholog
examin
repres
anim
demonstr
mening
inflamm
level
cerebr
hemispher
spinal
cord
perivascular
lymphocyt
cuff
distribut
throughout
spinal
cord
larg
lesion
thoracolumbar
cord
compris
mononuclear
inflammatori
infiltr
scatter
demyelin
axon
demyelin
inflamm
optic
nerv
chang
consist
eae
two
anim
fail
display
clinic
sign
adopt
transfer
x
exon
peptidesensit
cell
kill
week
transfer
time
point
symptomat
counterpart
continu
exhibit
deficit
interestingli
mice
small
cn
lesion
consist
inflammatori
infiltr
mening
lower
spinal
cord
fig
clinic
appear
symptomat
mice
receiv
exon
sensit
lnc
resembl
mice
receiv
gpmbpsensit
lnc
parallel
experi
howev
mice
former
group
invari
develop
less
sever
diseas
greater
number
lnc
requir
diseas
induct
tabl
similar
result
obtain
use
immunogen
data
shown
attempt
enhanc
respons
exon
peptid
perhap
produc
sever
diseas
lnc
mice
immun
exon
stimul
twice
prior
transfer
lnc
incub
exon
peptid
two
cycl
separ
loday
rest
period
transfer
dose
x
cell
mous
phenotyp
analysi
demonstr
line
anim
adopt
transfer
cell
becam
ill
without
manipul
diseas
gener
sever
major
mice
paralyz
hind
limb
peak
diseas
tabl
anim
follow
sever
relaps
fig
patholog
analysi
yield
find
typic
eae
extens
inflammatori
demyelin
involv
entir
neuroaxi
lesion
appear
pure
demyelin
murin
model
eae
axon
dystrophi
wallerian
degener
rare
seen
fig
twenti
control
anim
receiv
restimul
ppdspecif
cell
fail
develop
either
clinic
histolog
evid
diseas
tabl
second
seri
experi
enhanc
encephalogen
exon
peptid
consist
first
sensit
recipi
lnc
fig
small
subpial
lesion
seen
margin
lumbar
spinal
cord
mous
sensit
fig
remain
clinic
grade
asymptomat
sampl
day
posttransf
perivascular
cuff
shown
around
vessel
subarachnoid
space
overli
small
lesion
demyelin
axon
discern
magnif
x
clinic
cours
mice
inject
cell
line
specif
exon
peptid
lnc
obtain
mice
immun
exon
cfa
stimul
twice
vitro
inject
naiv
recipi
x
cellsmous
mice
examin
daili
sign
eae
grade
point
scale
diseas
sever
previous
describ
petinelli
et
al
repres
hindlimb
paralysi
repres
moribund
state
recipi
develop
eae
relapsingremit
cours
follow
muniz
donor
cell
reactiv
peptid
month
later
rechalleng
anim
fail
develop
eae
subcutan
inject
exon
peptid
cfa
techniqu
combin
adopt
transfer
antigen
challeng
origin
employ
induc
eae
reportedli
resist
strain
shaw
et
al
recipi
experi
display
clinic
sign
eae
within
day
post
antigen
challeng
includ
four
mice
initi
inject
x
cell
three
mice
inject
x
cell
five
mice
inject
x
cell
tabl
relapsingremit
cours
ensu
fig
histopatholog
examin
reveal
extens
inflammatori
lesion
along
entir
neuroaxi
larg
plaqu
ongo
demyelin
appar
spinal
cord
axon
dystrophi
wallerian
degener
spars
fig
macrophag
laden
myelin
debri
abund
lesion
fig
c
blind
observ
note
presenc
exon
anim
area
recent
activ
superimpos
upon
longstand
lesion
contain
remyelin
fiber
fig
other
display
fibrillari
astrogliosi
begin
separ
demyelin
axon
glial
scar
tissu
fig
f
latter
chronic
featur
consist
exist
subclin
lesion
activ
prior
secondari
challeng
presum
result
primari
adopt
transfer
exon
cell
result
control
anim
confirm
specif
diseas
exon
peptid
mice
receiv
ppdsensit
lnc
fail
develop
diseas
follow
ing
transfer
subsequ
upon
antigen
challeng
either
exon
peptid
cfa
ppd
alon
tabl
ten
mice
receiv
lnc
obtain
ppdimmun
donor
stimul
exon
peptid
vitro
one
develop
weak
tail
upon
antigen
challeng
exon
peptid
mening
infiltr
lower
spinal
cord
observ
histolog
analysi
anim
none
control
anim
display
evid
histolog
diseas
tabl
addit
anim
activ
immun
exon
peptid
cfa
remain
asymptomat
tabl
control
examin
daili
day
follow
antigen
challeng
immun
purpos
studi
examin
encephalogen
peptid
encod
exon
mbp
gene
sjlj
mous
previou
studi
eae
focuss
abund
kda
mbp
lnc
sjlj
mice
immun
antigen
cfa
stimul
twice
vitro
antigen
inject
naiv
sjlj
mice
cellsmous
quantiti
antigen
use
immun
vitro
stimul
found
produc
strongest
prolif
respons
previou
experi
data
shown
b
mean
number
day
adopt
transfer
first
sign
eae
shown
rang
bracket
mice
grade
five
point
clinic
scale
repres
hindlimb
paralysi
moribund
state
describ
text
mean
grade
height
diseas
sever
shown
rang
bracket
exon
refer
peptid
isoform
peptid
encephalitogen
petinelli
et
al
falli
et
al
fritz
et
al
attempt
identifi
uniqu
reactiv
mbp
ms
also
focus
kda
isoform
martin
et
al
recent
howev
evid
demonstr
reactiv
mbp
exon
peptid
emerg
studi
human
voskuhl
b
sinc
express
exon
isoform
increas
remyelin
jordan
et
al
encephalitogen
determin
within
region
mbp
molecul
might
contribut
diseas
progress
ms
relaps
form
eae
result
experi
demonstr
exon
peptid
inher
immunogen
sjlj
mice
eae
could
induc
adopt
transfer
exon
peptidespecif
lnc
furthermor
diseas
could
ac
lnc
obtain
mice
immun
exon
cfa
stimul
one
cycl
inject
naiv
recipi
x
cell
mous
anim
remain
asymptomat
day
post
transfer
immun
exon
cfa
mice
evalu
daili
grade
diseas
sever
manner
describ
fig
rechalleng
anim
develop
eae
reproduc
time
point
relapsingremit
cours
ensu
centuat
transfer
shortterm
exon
line
combin
adopt
transfer
antigen
challeng
histolog
analysi
exon
lesion
appear
pure
demyelin
compar
lesion
mous
model
eae
axon
dystrophi
wailerian
degener
rare
seen
site
immunodomin
epitopec
local
aa
sequenc
exclus
encod
exon
sinc
reactiv
sensit
lnc
encephalitogen
adopt
naiv
sjlj
mice
immun
either
exon
peptid
exon
cfa
cfa
alon
b
lnc
harvest
day
follow
immun
stimul
vitro
either
exon
ppd
day
concentr
found
maxim
prolifer
fig
anim
remain
asymptomat
day
post
transfer
immun
either
exon
cfa
cfa
alon
mean
number
day
antigen
challeng
first
sign
eae
shown
rang
parenthes
mean
clinic
grade
height
diseas
sever
shown
rang
parenthes
transfer
similar
use
either
exon
contain
region
overlap
exon
exon
encod
sequenc
reactiv
obtain
kda
isoform
mbp
includ
exon
peptid
henc
exon
peptid
specif
ad
list
encephalitogen
peptid
sjlj
mous
find
relev
sever
aspect
autoimmun
diseas
gener
eae
particular
first
abil
induc
eae
exon
peptid
demonstr
immunopatholog
diseas
could
elicit
autoantigen
normal
present
minut
quantiti
target
organ
studi
quantifi
rel
amount
mbp
isoform
adult
rodent
includ
mice
shown
exon
isoform
least
ten
time
scarcer
exon
isoform
barbares
et
al
kerelo
de
rosbo
et
al
exon
isoform
mbp
rel
abund
earli
myelinogenesi
rate
product
fall
dramat
matur
assess
either
quantit
immunoblot
situ
hybrid
analysi
myelin
gene
transcript
jordan
et
al
kerlero
de
rosbo
et
al
low
level
antigen
express
adult
cn
tissu
may
explain
requir
larg
number
exon
lnc
order
adopt
transfer
diseas
present
find
emphas
need
consid
even
minor
antigen
candid
target
antigen
autoimmun
diseas
second
implic
find
alter
express
self
antigen
might
heighten
import
autoantigen
aberr
condit
mention
previous
exon
express
report
increas
remyelin
exampl
use
model
viral
induc
demyelin
exon
transcript
describ
mous
spinal
cord
area
remyelin
kristenson
et
al
jordan
et
al
sinc
remyelin
occur
cyclic
cours
reae
brown
et
al
rain
et
al
cycl
remyelin
could
theoret
provid
scenario
activ
rest
exon
cell
cn
diseas
mice
secondari
increas
present
exon
peptid
condit
could
result
exon
lnc
encephalitogen
capac
contribut
diseas
progress
reae
perhap
ms
preliminari
studi
address
question
upregul
exon
isoform
cours
reae
undertaken
increas
product
exon
acontain
transcript
mice
chronic
reae
demonstr
situ
hybrid
perform
mous
spinal
cord
tissu
use
oligonucleotid
probe
specif
exon
mrna
b
segal
r
voskuhl
l
verma
n
gogt
unpublish
present
find
emphas
need
consid
myelin
constitu
candid
autoantigen
may
also
occur
small
amount
may
increas
remyelin
regard
charg
isom
mbp
contain
eight
citrullin
substitut
also
associ
remyelin
recent
describ
increas
white
matter
ms
patient
martin
r
prepar
cell
specif
isol
pbl
ms
patient
well
healthi
control
martin
et
al
increas
express
exon
remyelin
also
rais
question
regard
eas
diseas
could
induc
immun
exon
peptid
mice
previous
receiv
lnc
sensit
exon
peptid
remain
asymptomat
patholog
examin
two
asymptomat
recipi
kill
soon
predict
time
point
diseas
onset
reveal
lesion
consist
mild
encephalomyel
despit
fact
anim
never
exhibit
clinic
deficit
patholog
analysi
four
anim
treat
combin
adopt
transfer
antigen
challeng
demonstr
lesion
vari
age
remyelin
site
old
activ
appear
date
time
initi
cell
transfer
thu
subclin
demyelin
follow
remyelin
anim
receiv
exon
lnc
could
produc
upregul
express
exon
isoform
increas
antigen
present
turn
could
contribut
heighten
suscept
mice
upon
subsequ
antigen
challeng
previou
discuss
emphas
role
exon
lymphocyt
perpetu
autoimmun
diseas
rather
induct
scenario
lymphocyt
reactiv
exon
peptid
could
consid
exampl
determin
spread
lehmann
et
al
determin
within
exon
peptid
might
consid
cryptic
gammon
et
al
inaccess
circul
lnc
normal
condit
peptid
scarc
adult
cn
small
amount
peptid
present
sequest
behind
bloodbrain
barrier
bbb
cours
encephalomyel
howev
condit
alter
express
exon
peptid
could
theoret
upregul
remyelin
site
damag
bbb
would
compromis
site
henc
autoreact
repertoir
could
becom
skew
toward
cell
specif
determin
encod
exon
mbp
gene
therebi
produc
special
instanc
determin
spread
regard
definit
cryptic
epitop
unknown
whether
determin
exon
peptid
would
emerg
immunodomin
follow
sensit
whole
exon
mbp
isoform
howev
signific
prolif
respons
lnc
fig
suggest
exon
exon
exon
exon
exon
exon
exon
exon
exon
exon
exon
exon
ppd
ppd
ac
naiv
sjlj
mice
immun
exon
peptid
exon
cfa
cfa
alon
lnc
harvest
ten
day
later
incub
exon
ppd
respect
either
one
two
cycl
repres
anim
exon
eae
kill
exacerb
mice
rate
diseas
sever
day
sacrific
use
five
point
scale
describ
text
neg
control
mice
ex
kill
time
point
analog
symptomat
mice
mous
kill
day
follow
adopt
transfer
never
exhibit
sign
eae
e
mice
grade
accord
sever
inflammatori
demyelin
activ
cn
white
matter
use
point
scale
previous
describ
moor
et
al
ac
lnc
mice
immun
day
earlier
cfa
alon
exon
peptid
exon
cfa
stimul
vitro
day
either
ppd
exon
inject
naiv
recipi
x
cellsmous
mice
fail
exhibit
sign
eae
day
post
transfer
immun
either
ppd
exon
mice
kill
upon
develop
sign
eae
rate
point
scale
describ
text
asymptomat
control
mice
ex
kill
time
point
analog
symptomat
counterpart
mous
display
question
weak
tail
standard
latent
period
challeng
diseas
onset
observ
anim
treat
exclus
exon
e
histolog
specimen
cn
tissu
rate
accord
degre
inflammatori
demyelin
involv
base
upon
point
scale
outlin
moor
et
al
lymphocyt
reactiv
exon
peptid
activ
antigenpres
cell
process
larger
mbp
fragment
plan
investig
immunogen
kda
mbp
isoform
futur
experi
current
underway
determin
precursor
frequenc
exon
peptidespecif
cell
lymphoid
tissu
variou
stage
reae
simultan
measur
exon
peptid
express
cn
third
implic
find
en
spinal
cord
lesion
anoth
mous
rechalleng
manner
sampl
day
later
lesion
show
recent
inflammatori
activ
superimpos
upon
longstand
patholog
includ
remyelin
arrow
evidenc
thin
myelin
sheath
around
larg
diamet
axon
appear
suggest
lesion
activ
absenc
clinic
sign
prior
rechalleng
magnif
x
e
older
demyelin
lesion
seen
later
column
lumbar
spinal
cord
yet
anoth
anim
rechalleng
exon
month
adopt
transfer
exon
cell
period
anim
asymptomat
day
rechalleng
anim
display
eae
clinic
grade
sampl
studi
note
infiltr
cell
subarachnoid
space
demyelin
axon
amidst
glial
inflammatori
cell
lack
degen
chang
magnif
f
higher
magnif
e
show
mani
demyelin
axon
separ
invest
glial
scar
tissu
arrow
also
present
recent
inflammatori
cell
occasion
myelincontain
macrophag
pictur
suggest
coexist
acut
chronic
chang
within
lesion
magnif
x
cephalitogen
potenti
myelin
antigen
rel
strain
suscept
adopt
transfer
eae
exon
peptid
could
achiev
use
similar
number
lnc
experi
involv
kda
isoform
howev
sever
diseas
readili
induc
two
differ
techniqu
adopt
transfer
restimul
shortterm
line
combin
adopt
transfer
antigen
challeng
thu
peptid
consid
nonencephalitogen
might
reclassifi
encephalitogen
follow
applic
differ
techniqu
diseas
induct
murin
eae
model
mani
parallel
human
demyelin
diseas
ms
includ
patholog
appear
relaps
clinic
cours
lymphocyt
reactiv
exon
portion
human
mbp
deriv
pbl
ms
patient
control
multiplex
famili
member
demonstr
higher
frequenc
cell
specif
exon
peptid
immunodomin
epitop
within
kda
mbp
voskuhl
et
al
b
addit
remyelin
found
fresh
ms
plaqu
potenti
provid
sourc
newli
form
exon
isoform
analog
mechan
propos
murin
model
prinea
et
al
rain
et
al
though
difficult
determin
whether
exon
peptidespecif
lymphocyt
particip
pathogenesi
human
diseas
fact
encephalitogen
mous
support
need
investig
possibl
